维普中文期刊产品整合服务
32篇 您的检索式:作者名="Casslen"
    题名 作者 年代 出处 被引量
1Plasminogen activators and plasmingogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer显示文摘Casslen B Bossmar T Lecander I 1994Eur J Cancer1994,30,:1
2Plasminogen actiratora and plas-minogen activator inH1Bitors in blood and tumor fluds of patients coith ovain-an cancer显示文摘Casslen B Boss mar T Learder I 1994Ear J Cancer1994,30,9:1
3The G protein coupled estrogen receptor 1(GPER/GPR30)does not predict survival in patients with ovarian cancer显示文摘Kolkova Z Casslen V Henic E 2012J Ovarian Res2012,5,:1
4High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma 显示文摘Borgfeldt C Casslen B Liu CL 1998Int J Cancer1998,79,:1
5Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators(u-PA, t-PA) in endometrical carcinoma 显示文摘Nordengren J Casslen B Gustavsson B 1998Int Cancer1998,79,2:1
6Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture显示文摘Casslen B Andersson A Nilsson I M 0,,4:1
7Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells显示文摘Casslen B Urano S Ny T 0,,1:1
8Plasminogen activators and plasminogen activator inhibitors in blood and tumor fluids of patients coith ovarian cancer显示文摘Casslen B Bossmar T Leeander I 1994Eur J Cancer1994,30,9:1
9High tissue content of urokinase plasminogen activatou(u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma显示文摘Borgfeldt C Casslen B Liu CL 1998Int J Cancer1998,79,6:1
10High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma显示文摘 Casslen B Liu CL 1998Int Cancer1998,79,6:1
11J Clin Endocrinol显示文摘Casslen B 1995Metab1995,,80:1
12Plasminogen activators and plasmingngen activator inhibitors in blood and tumor fluids of patients with ovarian cancer显示文摘 Bossmar T Lecander I 1994Eur J Cancer1994,30,:1
13Prongestrone regulation of prolaction release from human endometrial stromal cells in culture : potential bioassay for progestational activity显示文摘Casslen B G Siler T M Harper J K 1990Acta Endocrinology1990,122,1:1
14Progesterone regulatin of prolactin release from human endometrial stromal cells in culture:potential bioassay for progestational activity显示文摘Casslen B G Siler T M Harper J K 1990Acta Endocrinol1990,122,1:1
15Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells显示文摘Casslen B Urano S Ny T 1992Thromb Res1992,66,1:1
16Fibrinolytic activity of human uterine fluid显示文摘Casslen B Astedt B 1981Acta Obstet Gynecol Scand1981,60,:1
17Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture显示文摘Casslen B Andersson A Nilsson I M Astedt B 1986Procsoc Exp Biol Med1986,192,:1
18Progestin stimulates degradation of urokinase plasminogen activator in endometrial stromal cells by increasing its inhibitor and surface expression of the uPA receptor显示文摘Casslen B Nordengren J Gustavsson B 1995J Clin Endocrinol Metab1995,80,:1
19Free amino acides in human uterine fluid possible role of hightaurine concentration显示文摘Casslen B G 1987Reprod Med1987,32,:1
20Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta 1;possible mechanism for paracrine stimulat显示文摘Sandberg T Casslen B Gustavsson B 0,,04:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费